RESEARCH Pain experience in childre d

ild high daily prevalence [1-3]. Low-dose methotrexate, a disease-modifying antirheumatic drug (DMARD), is con-have reported pain as an outcome measure, and those that do use only a single pain measure [7,11-14]. Although Lomholt et al. Pediatric Rheumatology 2013, 11:2